Bitters, GLP-1 and Metabolic Resilience: Herbal Solutions for Better Outcomes
MediHerb | 22 Oct 2026
GLP-1 analogue drugs have transformed obesity care, but they have also created new clinical challenges. Gastrointestinal intolerance, loss of lean mass, nutritional depletion and weight regain following treatment are becoming increasingly common concerns.
In this presentation, Professor Kerry Bone explores how Functional Herbal Therapy can help address these challenges. Drawing on emerging research in gut endocrinology, network pharmacology and systems biology, he will discuss evidence-informed strategies to improve tolerability, support metabolic health and assist long-term weight management.
You will discover the clinical relevance of bitter taste receptors, the gut microbiome, bile acid signalling and endogenous GLP-1 regulation, along with the evidence supporting herbs such as bitters, ginger, berberine and hops. Practical applications for patients using GLP-1 medications, transitioning off treatment or seeking non-pharmaceutical approaches will also be examined.
This session offers a fresh perspective on weight management, shifting the focus from appetite suppression alone toward lasting metabolic resilience.
Live Stream Times
- QLD: 12 - 1:30pm
- NSW, VIC, TAS, ACT: 1 - 2:30pm
- SA: 12:30 - 2pm
- NT: 11:30am - 1pm
- WA: 10 - 11:30am
- NZ: 3 - 4:30pm
Times on registration page reflect your local time.
If you are unable to attend live, the session recordings will be available within 10 business days.
Eligible for 1 CPE point.